A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
- 1 January 1982
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 45 (1) , 55-59
- https://doi.org/10.1136/jnnp.45.1.55
Abstract
Patients (88) with the onset of epilepsy in adult life were randomly allocated to treatment with sodium valproate (600 mg/day) or phenytoin (300 mg/day) and followed up for at least 12 mo. Both drugs were highly effective in the control of tonic-clonic seizures, irrespective of whether they were accompanied by focal features, but were markedly less effective in the control of partial seizures. Two patients exhibited acute allergic reactions to phenytoin. No significant differences have yet emerged in the efficacy of the 2 drugs and valproate may be considered as a 1st-line anticonvulsant in the treatment of adult onset epilepsy.This publication has 14 references indexed in Scilit:
- Comparison of Sodium Valproate and Phenytoin as Single Drug Treatment in EpilepsyEpilepsia, 1981
- Monotherapy or Poly therapy for Epilepsy?Epilepsia, 1981
- ACUTE LIVER DISEASE ASSOCIATED WITH SODIUM VALPROATEThe Lancet, 1980
- Acute intoxication with sodium valproateAnnals of Neurology, 1979
- One drug for epilepsy.BMJ, 1978
- Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)Developmental Medicine and Child Neurology, 1977
- Sodium ValproateDrugs, 1977
- SODIUM VALPROATE IN the TREATMENT of RESISTANT EPILEPSYActa Neurologica Scandinavica, 1976
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976
- Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A ReviewEpilepsia, 1975